The U.S. Food and Drug Administration in October approved Yescarta, a one-time, custom-made CAR-T treatment for aggressive lymphoma in adults.
CAR-T treatment uses gene therapy techniques not to fix disease-causing genes but to turbocharge T cells, immune system soldiers that cancer can often evade.
Source: Missouri resident among first to try new cancer treatment | Life | register-herald.com
END YOUR ILLNESS 